CARLSBAD, Calif., Dec. 18, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at JP Morgan 2013 Healthcare Conference on Tuesday, Jan. 8 at 1:30 p.m. PT. Gregory T. Lucier, Life Technologies' Chairman and Chief Executive Officer, will present on behalf of the company. The company will webcast the presentation, which will be available for three weeks following the conference, on the Life Technologies' investor relations website at ir.lifetechnologies.com/events.cfm.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company with customers in more than 160 countries using its innovative solutions to solve some of today's most difficult scientific challenges. Quality and innovation are accessible to every lab with its reliable and easy-to-use solutions spanning the biological spectrum, with more than 50,000 products for agricultural biotechnology, translational research, molecular medicine and diagnostics, stem cell-based therapies, forensics, food safety and animal health. Its systems, reagents and consumables represent some of the most cited brands in scientific research including: Ion Torrent™, Applied Biosystems®, Invitrogen™, Gibco®, Ambion®, Molecular Probes®, Novex®, and TaqMan®. Life Technologies employs approximately 10,400 people and upholds its ongoing commitment to innovation with more than 4,000 patents and exclusive licenses. LIFE had sales of $3.7 billion in 2011. Visit us at our website: http://www.lifetechnologies.com.
Investor and Financial Contact:
SOURCE Life Technologies Corporation